MRZ 2/576 je antagonist NMDA receptora.[3]

MRZ 2/576
8-chloro-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one;2-hydroxyethyl(trimethyl)azanium
Nazivi
IUPAC naziv
8-hloro-4,5-dihidroksipiridazino[4,5-b]hinolin-1-on;2-hidroksietil(trimetil)azanium
Drugi nazivi
  • SCHEMBL1932257
Identifikacija
3D model (Jmol)
  • C[N+](C)(C)CCO.C1=CC2=C(C=C1Cl)C=C3C(=C(N=NC3=O)O)N2O
Svojstva
C16H20ClN4O4
Molarna masa 367,81 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.